KCNJ6, potassium inwardly rectifying channel subfamily J member 6, 3763
N. diseases: 104; N. variants: 110
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 21 | 37714662 | synonymous variant | T/C | snv | 0.80 | 0.85 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
1.000 | 0.040 | 21 | 37714662 | synonymous variant | T/C | snv | 0.80 | 0.85 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
21 | 37811882 | intron variant | G/C;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.200 | 21 | 37645860 | intron variant | T/C | snv | 0.16 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.200 | 21 | 37645860 | intron variant | T/C | snv | 0.16 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.200 | 21 | 37645860 | intron variant | T/C | snv | 0.16 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.120 | 21 | 37749345 | intron variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.120 | 21 | 37749345 | intron variant | C/A;T | snv |
|
0.010 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
1.000 | 0.120 | 21 | 37749345 | intron variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.120 | 21 | 37749345 | intron variant | C/A;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.120 | 21 | 37834589 | intron variant | C/T | snv | 0.21 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.120 | 21 | 37834589 | intron variant | C/T | snv | 0.21 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.080 | 21 | 37840718 | intron variant | G/A | snv | 0.59 | 0.58 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.925 | 0.080 | 21 | 37840718 | intron variant | G/A | snv | 0.59 | 0.58 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
1.000 | 0.040 | 21 | 37916637 | intron variant | A/G | snv | 0.69 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
21 | 38084132 | intron variant | T/A | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 21 | 37652469 | intron variant | T/C | snv | 0.26 |
|
Chemically-Induced Disorders; Mental Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 21 | 37652469 | intron variant | T/C | snv | 0.26 |
|
Chemically-Induced Disorders; Mental Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 21 | 37652469 | intron variant | T/C | snv | 0.26 |
|
Chemically-Induced Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 21 | 37638374 | intron variant | C/A;T | snv | 0.27 |
|
Chemically-Induced Disorders; Mental Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 21 | 37638374 | intron variant | C/A;T | snv | 0.27 |
|
Chemically-Induced Disorders; Mental Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 21 | 37638374 | intron variant | C/A;T | snv | 0.27 |
|
Chemically-Induced Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 21 | 37617262 | 3 prime UTR variant | A/G | snv | 0.32 |
|
Chemically-Induced Disorders; Mental Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 21 | 37617262 | 3 prime UTR variant | A/G | snv | 0.32 |
|
Chemically-Induced Disorders; Mental Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 21 | 37617262 | 3 prime UTR variant | A/G | snv | 0.32 |
|
Chemically-Induced Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 |